Michael J. Derelanko

Potent, Orally Bioavailable Delta Opioid Receptor Agonists for the Treatment of Pain: Discovery of<i>N</i>,<i>N</i>-Diethyl-4-(5-hydroxyspiro[chromene-2,4′-piperidine]-4-yl)benzamide (ADL5859)

Bertrand Le Bourdonnec, Rolf T. Windh, Christopher W. Ajello et al. · Journal of Medicinal Chemistry · 2008 · 89 citations · Full text

Spirocyclic Delta Opioid Receptor Agonists for the Treatment of Pain: Discovery of<i>N</i>,<i>N</i>-Diethyl-3-hydroxy-4-(spiro[chromene-2,4′-piperidine]-4-yl) Benzamide (ADL5747)

Bertrand Le Bourdonnec, Rolf T. Windh, Lara K. Leister et al. · Journal of Medicinal Chemistry · 2009 · 83 citations · Full text

Determination of Erythrocyte Life Span in F-344, Wistar, and Sprague-Dawley Rats Using a Modification of the [³H]Diisopropylfluorophosphate ([³H]DFP) Method

Michael J. Derelanko · Toxicological Sciences · 1987 · 62 citations

Gastric antisecretory and cytoprotective activities of SCH 28080.

John F. Long, Peter Chiu, Michael J. Derelanko et al. · Journal of Pharmacology and Experimental Therapeutics · 1983 · 62 citations

Innovative Designs and Practices for Acute Systemic Toxicity Studies

Shayne C. Gad, Adaline C. Smith, Anne L. Cramp et al. · Drug and Chemical Toxicology · 1984 · 47 citations